X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
12
PharmaCompass offers a list of Fosnetupitant Chloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fosnetupitant Chloride manufacturer or Fosnetupitant Chloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosnetupitant Chloride manufacturer or Fosnetupitant Chloride supplier.
PharmaCompass also assists you with knowing the Fosnetupitant Chloride API Price utilized in the formulation of products. Fosnetupitant Chloride API Price is not always fixed or binding as the Fosnetupitant Chloride Price is obtained through a variety of data sources. The Fosnetupitant Chloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 08-PNET manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 08-PNET, including repackagers and relabelers. The FDA regulates 08-PNET manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 08-PNET API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 08-PNET manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 08-PNET supplier is an individual or a company that provides 08-PNET active pharmaceutical ingredient (API) or 08-PNET finished formulations upon request. The 08-PNET suppliers may include 08-PNET API manufacturers, exporters, distributors and traders.
click here to find a list of 08-PNET suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 08-PNET DMF (Drug Master File) is a document detailing the whole manufacturing process of 08-PNET active pharmaceutical ingredient (API) in detail. Different forms of 08-PNET DMFs exist exist since differing nations have different regulations, such as 08-PNET USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 08-PNET DMF submitted to regulatory agencies in the US is known as a USDMF. 08-PNET USDMF includes data on 08-PNET's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 08-PNET USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 08-PNET suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 08-PNET Drug Master File in Japan (08-PNET JDMF) empowers 08-PNET API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 08-PNET JDMF during the approval evaluation for pharmaceutical products. At the time of 08-PNET JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 08-PNET suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 08-PNET Drug Master File in Korea (08-PNET KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 08-PNET. The MFDS reviews the 08-PNET KDMF as part of the drug registration process and uses the information provided in the 08-PNET KDMF to evaluate the safety and efficacy of the drug.
After submitting a 08-PNET KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 08-PNET API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 08-PNET suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 08-PNET as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 08-PNET API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 08-PNET as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 08-PNET and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 08-PNET NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 08-PNET suppliers with NDC on PharmaCompass.
08-PNET Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 08-PNET GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 08-PNET GMP manufacturer or 08-PNET GMP API supplier for your needs.
A 08-PNET CoA (Certificate of Analysis) is a formal document that attests to 08-PNET's compliance with 08-PNET specifications and serves as a tool for batch-level quality control.
08-PNET CoA mostly includes findings from lab analyses of a specific batch. For each 08-PNET CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
08-PNET may be tested according to a variety of international standards, such as European Pharmacopoeia (08-PNET EP), 08-PNET JP (Japanese Pharmacopeia) and the US Pharmacopoeia (08-PNET USP).
Market Place
